• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Remote Care Source Launches COVID-19 Telemedicine Solution for US Hospitals


Leveraging experience in monitoring coronavirus symptoms, Datos health, an Israeli telehealth company, releases solution to avoid low-risk patients in overwhelming hospitals.


Datos, a provider of an automated remote care platform, recently announced the availability of its agile and comprehensive telemedicine solution for remote monitoring of coronavirus patients.

As COVID-19 continues to spread, hospitals are expecting a surge in visitors to clinics and emergency rooms, which would result in a challenging additional burden on an already overstretched medical system. Datos’s solution, easily implemented within 24 hours, is specifically designed to support hospitals across the world mitigate such a situation by helping to keep suspected corona patients, and those infected but not requiring hospitalization, at home while still providing them with optimal care, according to a release.

Hospitals and HMOs will be able to quickly deploy a robust and scalable COVID-19 telemedicine solution tailored to provide virtual services including online symptom-checking tools and remote consultations with doctors, while simultaneously minimizing direct contact with those infected with the coronavirus.

The Datos COVID-19-specific telemedicine package is already in use at Sheba Medical Center, Israel’s largest hospital, and has begun implementations in U.S. hospital systems.

Related: Will COVID-19 Supply Telehealth Its Moment?

“Datos is providing an important solution for the U.S. healthcare system to monitor COVID-19 remotely, easing the demand for inpatient-based monitoring at hospitals,” says Uri Bettesh, CEO of Datos Health. “The first solution of its kind, we are able to deploy it within 48 hours (as of March 17). It requires no additional resources as it seamlessly integrates with care teams’ existing workflows, providing crucial insights into patients being monitored outside the hospital at a fraction of the cost. Treating patients-who do not require hospitalization-out of emergency rooms could ensure that key resources are available for the most serious cases.”  

The Datos COVID-19 solution offers:

  • For care teams: a fully configured COVID-19 dashboard that includes an overall view of all patients-sorted according to the severity of coronavirus symptoms, the delivery of daily symptom checkout surveys, the seamless launch of virtual visits via video calls (including via text message, without requiring the Datos app), data-driven reminders (to measure temperature and complete surveys), messages and content.

  • For patients: a user-friendly mobile app (available on iOS and Android) for home hospitalized patients to manually enter their relevant vitals, including body temperature, blood pressure, and saturation. Patients will be asked to respond to two types of coronavirus surveys, an initial assessment followed by daily symptom status updates, sent automatically and then scored and correlated with monitored vitals to yield timely reminders, personalized messages and virtual doctor visits via video calls.

The solution additionally provides health systems with a private, HIPAA compliant, cloud-based interface of the Datos platform anywhere in the world. Optional extras include services delivered via a text message with links to web pages for reporting vitals management, survey distribution, and video calls.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.